Pharmaceuticals
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 29.
Slingshot Software Launches Release 11.0 of Enterprise Business Software Suite
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Slingshot Software today announced the release of version 11.0 of its enterprise business software suite. Release 11.0 features a new AJAX-based user interface (UI) for all of Slingshot’s Web-based applications, as well as more than 75 infrastructure and application enhancements. (PRWeb Oct 28, 2009)
Read the full story at http://www.prweb.com/releases/slingshot-software/announces-release-11/prweb3121074.htm
Source: PRWeb: Medical Pharmaceuticals - October 28, 2009 Category: Pharmaceuticals Source Type: news
Impact Unlimited Three-Time Winner At 35th Annual Jasper AwardsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Impact Unlimited, a leading provider of brand communications for events, exhibits, and meetings worldwide, took home three Gold Awards at the 35th Annual Jasper Awards on October 9, 2009. The awards dinner, hosted by the Jersey Shore Public Relations and Advertising Association, (JSPRAA) was held at the Robert Meyner Reception Center in Holmdel, N.J. Impact Unlimited took the gold for all three categories in which it was nominated: the Environmental Design for Tradeshow Graphics/Display, Special Event Planning for the Seminar/Workshop, and Special Event Planning for Tradeshow planning. (PRWeb Oct 28, 2009)
Read the ful...
Source: PRWeb: Medical Pharmaceuticals - October 28, 2009 Category: Pharmaceuticals Source Type: news
GSK delivers Q3 EPS of 28.5p before major restructuring and dividend of 15p up 7%Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
- Return to sales growth with Q3 turnover +3% CER; +15%
sterling
- Continued improvement expected in Q4
Summary
Portfolio diversification and investment in key areas drives
return to sales growth: Emerging Markets (+25%); Japan (+19%) and
Consumer...
Source: Drugs.com - Pharma News - October 28, 2009 Category: Pharmaceuticals Source Type: news
StemCells to raise $12.5M in stock saleEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
StemCells Inc. said Wednesday it plans to raise approximately $12.5 million through the sale of about 10 million shares of its common stock. (STEM)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 28, 2009 Category: Pharmaceuticals Source Type: journals
Safeguard Scientifics leads Quinnova fundingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Quinnova Pharmaceuticals raised $17.4 million in a venture capital financing Wednesday led by Safeguard Scientifics. (SFE)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 28, 2009 Category: Pharmaceuticals Source Type: journals
Novavax Indian joint venture starts vaccine productionsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Novavax Inc., which last week announced a vaccine production partnership in Mexico, is beginning work using its production technology with a partner in India. (NVAX)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 28, 2009 Category: Pharmaceuticals Source Type: journals
Neurobiological Technologies liquidation gets stockholders OKEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Stockholders voted in favor of a plan to liquidate and dissolve Neurobiological Technologies Inc. (NTII)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 28, 2009 Category: Pharmaceuticals Source Type: journals
FDA Sends Letter to Sanofi-Aventis Regarding Uroxatral PromotionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ROCKVILLE, Md., Oct. 27, 2009--The FDA today posted on its
website a letter sent to Sanofi-Aventis regarding a voucher tent
card for Uroxatral. The letter is below.
Joanne Robinett
sanofi-aventis U.S. LLC
P.O. Box 5925
55 Corporate...
Source: Drugs.com - Pharma News - October 28, 2009 Category: Pharmaceuticals Source Type: news
Transcend Services has big revenue jumpEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Transcend Services Inc.’s profit increased 24 percent in the third quarter. (TRCR)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 28, 2009 Category: Pharmaceuticals Source Type: journals
Neurobiological Technologies Announces Stockholder Approval of Plan of Liquidation and DissolutionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Board of Directors Declares Extraordinary Dividend of $0.75
per share
EMERYVILLE, Calif., Oct. 28 /PRNewswire-FirstCall/ --
Neurobiological Technologies, Inc. (NASDAQ:NTII) ("NTI") announced today that its
stockholders have voted in favor of the...
Source: Drugs.com - Pharma News - October 28, 2009 Category: Pharmaceuticals Source Type: news
Ranbaxy-Daiichi working on a 3-year plan for synergising opsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Ranbaxy Laboratories and its Japanese parent Daiichi Sankyo are working on a three-year plan for exploiting synergies in operations to enhance their generic as well as branded business across the globe.
Source: The Economic Times Healthcare and Biotech News - October 28, 2009 Category: Pharmaceuticals Source Type: news
SciClone to cut 17% of U.S. employeesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SciClone Pharmaceuticals Inc. will cut 17 percent of its U.S. employees to save money. (SCLN)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 28, 2009 Category: Pharmaceuticals Source Type: journals
Pozen hits on profit, misses on revenueEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Pozen Inc. on Wednesday reported it had topped Wall Street estimates for third quarter earnings but fell just short on revenue. (GSK)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 28, 2009 Category: Pharmaceuticals Source Type: journals
Glaxo's Net Surges on Weak PoundEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The U.K. drug maker reported strong profit and sales growth in the third quarter, helped by a weaker pound and acquisitions, and said the pace of its H1N1 vaccine production is improving.
Source: WSJ.com: Health - October 28, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
WellPoint 3Q profit down 11 percentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A drop in enrollment prompted by the economic downturn and continued high unemployment led health insurer WellPoint Inc. to an 11 percent decline in third-quarter profit. (WLP)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 28, 2009 Category: Pharmaceuticals Source Type: journals
Osteotech's MagniFuse(TM) Technology Used in First U.S. SurgeryEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MagniFuse Offers New Therapeutic Option with Technological, Surgical and Economic Advantages
EATONTOWN, N.J., Oct. 28 (HSMN NewsFeed) -- Osteotech, Inc. (Nasdaq: OSTE ), a leader in the emerging field of biologic products for regenerative healing, ann... Devices, Orthopaedic, NeurosurgeryOsteotech, MagniFuse PC, Bone Graft, posterior cervical fusion, spine surgery
Source: HSMN NewsFeed - October 28, 2009 Category: Pharmaceuticals Source Type: news
SciClone Announces Corporate Restructuring and Workforce ReductionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FOSTER CITY, CA, Oct., 28--(HSMN NewsFeed) - SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN ) today announced a corporate restructuring that will reduce its U.S.-based workforce by approximately 17%, primarily in research and development. This restructuring f... BiopharmaceuticalsSciClone Pharmaceuticals
Source: HSMN NewsFeed - October 28, 2009 Category: Pharmaceuticals Source Type: news
FDA Clears Interlace Medical's MyoSure(TM) Hysteroscopic Tissue Removal System for The Treatment of Submucosal FibroidsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FRAMINGHAM, Mass., Oct., 28--(HSMN NewsFeed)--Interlace Medical, Inc., today announced that it has received 510K clearance from the U. S. Food and Drug Administration (FDA) to market the MyoSure Hysteroscopic Tissue Removal System for the removal of submuc... Devices, FDAInterlace Medical, MyoSure, Hysteroscopic Tissue Removal, fibroid
Source: HSMN NewsFeed - October 28, 2009 Category: Pharmaceuticals Source Type: news
Toshiba Introduces the Infinix VF-i/BP Vascular X-Ray System with Large and Mid-Sized Flat Panel DetectorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
New Infinix System is the Optimal Universal Bi-plane Configuration
TUSTIN, Calif., Oct., 28--(HSMN NewsFeed)--Increasing the flexibility and diagnostic capabilities in bi-plane vascular X-ray imaging, Toshiba America Medical Systems, Inc. introduces the... Devices, RadiologyToshiba America Medical Systems, Infinix VF-i/BP, vascular X-ray system
Source: HSMN NewsFeed - October 28, 2009 Category: Pharmaceuticals Source Type: news
Nabriva Therapeutics Raises Euro 15 Million (USD 22 Million)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VIENNA, Oct., 28--(HSMN NewsFeed)--Nabriva Therapeutics, a biotechnology company focused on developing a new class of antibiotics for serious infections caused by resistant pathogens, today announced the closing of a EUR 15 Million financing, bringing the ... Biopharmaceuticals, Venture CapitalNabriva Therapeutics, cSSSI
Source: HSMN NewsFeed - October 28, 2009 Category: Pharmaceuticals Source Type: news
Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney DiseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FOSRENOL(R) (lanthanum carbonate) Now Approved in the EU to Treat hyperphosphataemia >1.78mmol/L in Chronic Kidney Disease Patients Not on Dialysis
DUBLIN, October 28 (HSMN NewsFeed) -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biop... Biopharmaceuticals, RegulatoryShire Plc, FOSRENOL, lanthanum carbonate
Source: HSMN NewsFeed - October 28, 2009 Category: Pharmaceuticals Source Type: news
Emerging Stock Report Initiates Independent Research Coverage on XTEND MEDICAL CORPEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CALGARY, Alberta, Oct. 28, 2009 (GLOBE NEWSWIRE) -- Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on XTEND MEDICAL CORP. (Pink Sheets:XMDC). Emerging Stock Report is currently offering a complimentary trial subscription. To view our research go to: http://www.emergingstockreport.com.
Source: Medical News (via PRIMEZONE) - October 28, 2009 Category: Pharmaceuticals Source Type: news
Emerging Stock Report Initiates Independent Research Coverage on SK3 Group, Inc. (SKTO)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CALGARY, Alberta, Oct. 28, 2009 (GLOBE NEWSWIRE) -- Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on SK3 Group, Inc. (Pink Sheets:SKTO). Emerging Stock Report is currently offering a complimentary trial subscription. To view our research go to: http://www.emergingstockreport.com.
Source: Medical News (via PRIMEZONE) - October 28, 2009 Category: Pharmaceuticals Source Type: news
BioCurex Shareholders Overwhelmingly Approve Increase in Company's Capitalization and Name ChangeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
RICHMOND, British Columbia, Oct. 28, 2009 (GLOBE NEWSWIRE) -- Whispering Oaks International, Inc., d/b/a BioCurex (OTCBB:BOCX) announced today that at a special meeting of shareholders on October 27, 2009, its shareholders overwhelmingly approved the proposals to change its legal name to BioCurex, Inc. and to increase the Company's capitalization to 450,000,000 shares of common stock. The Company has been conducting business under the trade name "BioCurex." The proposals were approved by more than 70% of the shares eligible to vote at the meeting and by more than 95% of the voted shares.
Source: Medical News (via PRIMEZONE) - October 28, 2009 Category: Pharmaceuticals Source Type: news
Emerging markets offset US weakness at GSKEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Strong growth in emerging markets and Japan, and in consumer healthcare products, offset declines in US pharmaceuticals, but the drugs group expects strong sales of flu vaccine
Source: FT.com - Drugs and Healthcare - October 28, 2009 Category: Pharmaceuticals Source Type: news
Chelsea Therapeutics to Host Conference Call to Discuss Third Quarter 2009 ResultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CHARLOTTE, N.C., Oct. 28, 2009 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it will release third quarter results for the period ended September 30, 2009 after the market closes on Monday, November 2, 2009. Chelsea management will host a conference call and live webcast to discuss these financial results and provide an update on each of its development programs that afternoon at 4:30 PM ET.
Source: Medical News (via PRIMEZONE) - October 28, 2009 Category: Pharmaceuticals Source Type: news
WellPoint Profit Drops Amid Write-DownsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WellPoint's earnings fell 11% amid declining enrollments and asset write-downs. The health insurer also lowered its 2009 earnings forecast.
Source: WSJ.com: Health - October 28, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
Interim Results from Study 107 Highlight the Potential Role of Telaprevir-Based Regimens in HCV Patients Who Failed Prior TreatmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
57% of prior treatment
null responder patients achieved an SVR with a 48-week
telaprevir-based regimen
90% of prior treatment
relapsers and 55% of prior treatment partial responders achieved an
SVR with 24-week or 48-week telaprevir-based...
Source: Drugs.com - Clinical Trials - October 28, 2009 Category: Pharmaceuticals Source Type: clinical trials
Glaxo's Net Surges on Emerging MarketsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
GlaxoSmithKline reported a 30% rise in third quarter profit as a growing focus on emerging markets, Japan and consumer health-care products drove a return to growth.
Source: WSJ.com: Health - October 28, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
Integra LifeSciences to Present at the Oppenheimer 20th Annual Healthcare ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PLAINSBORO, N.J., Oct. 28, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the Oppenheimer 20th Annual Healthcare Conference.
Source: Medical News (via PRIMEZONE) - October 28, 2009 Category: Pharmaceuticals Source Type: news
Results announcement for the third quarter 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
GlaxoSmithKline plc (GSK) announced third quarter results for 2009
Source: GSK news - October 28, 2009 Category: Pharmaceuticals Source Type: organizations
ThromboGenics And BioInvent Complete Patient Recruitment Of Phase II DVT Prophylaxis Study With Anti-Factor VIII (TB-402)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (OMXS: BINV) announce that they have completed recruitment of their Phase II trial of TB-402 ahead of schedule.
Source: Pharmaceutical Online News - October 28, 2009 Category: Pharmaceuticals Source Type: news
Interim Results From Study 107 Highlight The Potential Role Of Telaprevir-Based Regimens In HCV Patients Who Failed Prior TreatmentEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Vertex Pharmaceuticals Incorporated announced today that treatment with telaprevir-based regimens in Study 107 resulted in high sustained viral response (SVR) rates in treatment-failure patients infected with hepatitis C virus (HCV).
Source: Pharmaceutical Online News - October 28, 2009 Category: Pharmaceuticals Source Type: news
WellPoint Profit Drops Amid Write-DownsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WellPoint's earnings fell 11% amid declining enrollments and asset write-downs. The health insurer also lowered its 2009 earnings forecast.
Source: WSJ.com: Health - October 28, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
Trading Outlook for Incyte Corp. Issued by StockPreacher.comEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DALLAS, Oct. 28, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring biopharmaceutical company Incyte Corp. (Nasdaq:INCY). The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.
Source: Medical News (via PRIMEZONE) - October 28, 2009 Category: Pharmaceuticals Source Type: news
Watson and Barr Settle Lawsuit Over Oxytrol®Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that its subsidiary Watson Laboratories, Inc. has reached a settlement with Barr Laboratories, Inc. on outstanding patent litigation related to Watson's Oxytrol® (Oxybutynin Transdermal System, 3.9mg/24hr.) product.
Source: Pharmaceutical Online News - October 28, 2009 Category: Pharmaceuticals Source Type: news
Eriez® Adds State-Of-The-Art Robotic Welder To Support Its Erie WorkforceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Eriez®, world authority in advanced technology for magnetic, vibratory and inspection applications, recently announced the purchase of a sophisticated robotic welder designed to improve efficiency, maintain accuracy and more quickly and economically meet increasing production volumes, according to Tim Shuttleworth, President and CEO. Shuttleworth went on to say, "With August being a record month for order bookings, this capital equipment will be instantly utilized."
Source: Pharmaceutical Online News - October 28, 2009 Category: Pharmaceuticals Source Type: news
Public Option Creates Barriers for BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sen. Harry Reid's push for a public option is creating new obstacles for health-care legislation, while Sen. Joe Lieberman said he would vote to block passage of the bill in its current form.
Source: WSJ.com: Health - October 28, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Medtronic Launches New Neuro Oncology Surgical Imaging System InternationallyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PoleStar(R) N30 Surgical MRI for Neurosurgery Designed to Optimize Tumor Resection Procedures
MINNEAPOLIS--(HSMN NewsFeed)--This week at the annual Congress of Neurological Surgeons (CNS), Medtronic (NYSE: MDT ) announced the Conformite Europeen (CE) ma... Devices, Neurosurgery, RadiologyMedtronic, PoleStar N30, Surgical MRI system, imaging
Source: HSMN NewsFeed - October 28, 2009 Category: Pharmaceuticals Source Type: news
Accuray's Treatment Planning Service Active at 20 Percent of U.S. CyberKnife CentersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Service Offers Specialized Physicist Support to New and Existing CyberKnife Sites
SUNNYVALE, Calif., Oct. 27 (HSMN NewsFeed) -- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that 20 percent of the ... Devices, OncologyAccuray, radiosurgery, CyberKnife
Source: HSMN NewsFeed - October 28, 2009 Category: Pharmaceuticals Source Type: news
Melody(R) Transcatheter Valve Demonstrates Encouraging Results in Study on Patients with Congenital Heart DiseaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Investigational Medical Device Offers Minimally Invasive Alternative to Open-Heart Surgery
MINNEAPOLIS--(HSMN NewsFeed)--Clinical trial results published in this weeks Journal of the American College of Cardiology (JACC) describe six-month outcomes for... Devices, Interventional CardiologyMedtronic, Melody valve, Transcatheter Pulmonary Valve
Source: HSMN NewsFeed - October 28, 2009 Category: Pharmaceuticals Source Type: news
Public Option Creates Barriers for BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Sen. Harry Reid's push for a public option is creating new obstacles for health-care legislation, while Sen. Joe Lieberman said he would vote to block passage of the bill in its current form.
Source: WSJ.com: Health - October 28, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Schwarzenegger Urges Health OverhaulEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
California's Schwarzenegger urged lawmakers to pass a health-care package by the end of the year, while saying he opposed some elements of the current proposal.
Source: WSJ.com: Health - October 28, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Nevada Case Spurs Pharmacies' FearsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A Nevada lawsuit over a fatal car accident is part of a broader movement under way to place more responsibility for patients' prescription-drug use on pharmacies.
Source: WSJ.com: Health - October 28, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
Antipsychotics Linked to Weight GainEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Antipsychotic drugs widely used in children caused youths to gain as much as 19 pounds on average after just 11 weeks on the medications, according to a new study published in the Journal of the American Medical Association.
Source: WSJ.com: Health - October 28, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Schwarzenegger Urges Health OverhaulEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
California's Schwarzenegger urged lawmakers to pass a health-care package by the end of the year, while saying he opposed some elements of the current proposal.
Source: WSJ.com: Health - October 28, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Pandemrix™ data in an elderly populationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
GlaxoSmithKline (GSK) announced that this week, approximately half a million people will have received its pandemic H1N1 vaccine, Pandemrix™, as part of Government initiated vaccination programmes across Europe, which commenced earlier this month. GSK also announced new results from a clinical trial assessing the use of Pandemrix in adults aged 18 to 85 years of age.
Source: World Pharma News - October 28, 2009 Category: Pharmaceuticals Source Type: news
